Within the same tissue, there was a trend toward Cldn1 expression in intermediate-to-poorly differentiated pancreatic cancers, even when Cldn1 expression was weak or absent in well-differentiated pancreatic cancers (Figure 1H). This evidence concerns the gene CLDN1 and pancreatic neoplasm.